The company mainly focuses on the R&D, production, sales and related industries of in vitro diagnostic reagents, and currently has 100,000-grade clean production workshop, 10,000-grade clean production workshop, 2,400 square meters of laboratory, 3,000 square meters of room temperature warehouse, 300 cubic meters of cold storage. The second phase of the project has been approved and is under construction, covering an area of 40 mu, with a total investment of 260 million yuan, and is expected to have an annual capacity of 50 million copies and an annual output value of more than 300 million yuan after completion.
At present, the company has 16 independent intellectual property rights, 8 domestic product registration/record certificates for medical devices, 7 foreign CE product registration certificates, and more than 10 R&D projects; its development is based on five technology platforms: colloidal gold platform, dry chemistry platform, molecular diagnosis platform, sample collection platform, and sterilization protection platform.
Canine coronavirus
For Canine coronavirus, everyone has different special concerns about it, and what we do is to maximize the product requirements of each customer, so the quality of our Canine coronavirus has been well received by many customers and enjoyed a good reputation in many countries. xjwondfoCanine coronavirus have characteristic design & practical performance & competitive price, for more information on the Canine coronavirus, please feel free to contact us.
Our company focuses on the research, development, production, sales and related biochemical of in vitro diagnostic reagents, and specializes in the production and supply of IVD medical related supplies.
+86-158-0991-7255 gracie@yufubio.com.cn Room 607, Buliding B, Tianhe New City Square, No.38 East Henan Road, New Urban District, Urumqi, Xinjiang, P.R. China
